Dimethylamine

Dimethylamine

SCHEMBL5358041

CNC.COc1ccc(-c2ccc(C)nc2-c2ccc(OC)cc2)cc1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.50
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 3/20 0.46
MAPT P10636 1/20 0.46
SYK P43405 3/20 0.46
AURKB Q96GD4 2/20 0.46
INCENP Q9NQS7 2/20 0.46
HPGD P15428 1/20 0.45
TGFBR1 P36897 1/20 0.45
MAPK14 Q16539 1/20 0.45
LMNA P02545 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PTGS2 P35354 1/20 0.41
PDE10A Q9Y233 1/20 0.41
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL9695311 0.98 KMT2A (0.49) KMT2AALDH1A1KDM4EMAPTSYK
Hydrochloric Acid SCHEMBL5904242 0.93 KMT2A (0.53) KMT2AALDH1A1KDM4ESYKAURKB
SCHEMBL8678271 0.89 ESR2 (0.56) KMT2AKDM4EMAPTSYKAURKB
SCHEMBL8809349 0.79 ESR1 (0.49) KMT2ASYKAURKBINCENPADORA1
SCHEMBL8678444 0.79 NPSR1 (0.55) KMT2AALDH1A1KDM4EMAPTSYK
SCHEMBL4037256 0.77 ALDH1A1 (0.57) ALDH1A1KDM4ESYKAURKBINCENP
SCHEMBL8809840 0.75 LTA4H (0.56) ALDH1A1KDM4EMAPTTDP1CYP1A2
SCHEMBL8808818 0.74 LTA4H (0.55) ALDH1A1KDM4EMAPTTDP1CYP1A2
SCHEMBL5904299 0.73 ADORA1 (0.54) KMT2AALDH1A1KDM4EMAPTHPGD
SCHEMBL5365571 0.73 KMT2A (0.50) KMT2AALDH1A1KDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7271266-B2 Substituted 2,3-diphenyl pyridines MERCK & CO., INC. (US) 2007-09-18 US disclosed
US-20050182103-A1 Substituted 2,3-diphenyl pyridines MERCK SHARP & DOHME CORP. 2005-08-18 US disclosed
EP-1492784-A2 SUBSTITUTED 2,3-DIPHENYL PYRIDINES Merck & Co., Inc. (US) 2005-01-05 EP disclosed
WO-2003082191-A2 SUBSTITUTED 2,3-DIPHENYL PYRIDINES MERCK & CO., INC. (US) 2003-10-09 WO disclosed
WO-1992002513-A1 HETEROCYCLIC COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182103-A1 Substituted 2,3-diphenyl pyridines CNR1, CNR2, MAG KMT2A 2706/4885ALDH1A1 2993/4885KDM4E 1804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.